Pure Global
NCT06402344

Gestrinone and Endothelial Function in Young Women

Association of Hormonal Implant With Gestrinone on Endothelial Function in Young Women
Hospital Israelita Albert Einstein·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Hormones; Abuse,Cardiovascular Diseases
Drug/Device/Intervention
Hormonal implant
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Hospital Israelita Albert Einstein
Location
São Paulo, Brazil
Timeline & enrollment
Phase
N/A
Start date
May 27, 2024
End date
Dec 30, 2025
Enrollment
90 participants
Primary outcome

Endothelial function

Summary

The purpose of this study is to assess the association of misuse of hormonal implant with
 gestrinone in cardiovascular health outcomes in young women.

ICD-10 classifications
Other endocrine disordersOther postprocedural endocrine and metabolic disordersOther specified endocrine disordersOther cardiovascular disorders originating in the perinatal periodOther adrenogenital disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06402344
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06402344 through Pure Global AI's free database. This phase not specified trial is sponsored by Hospital Israelita Albert Einstein and is currently Recruiting. The study focuses on Hormones; Abuse,Cardiovascular Diseases. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.